Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial.
paper
Cited
Public
Unavailable
- Authors
- Hayes, R B; Reding, D; Kopp, W; Subar, A F; Bhat, N; Rothman, N; Caporaso, N; Ziegler, R G; Johnson, C C; Weissfeld, J L; Hoover, R N; Hartge, P; Palace, C; Gohagan, J K; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team
- Year
- 2000
- Journal
- Controlled clinical trials
- PMID
- 11189687
- DOI
- 10.1016/s0197-2456(00)00101-x
The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, which is randomizing 74,000 screening arm participants (37,000 men, 37,000 women; ages 55-74) and an equal number of nonscreened controls, is a unique setting for the investigation of the etiology of cancer and other diseases and for the evaluation of potential molecular markers of early disease. At entry, baseline information is collected by questionnaire on dietary intake, tobacco and alcohol use, reproductive history (for women), family history of cancer, use of selected drugs, and other selected risk factors. Blood samples collected at the baseline screening exam are aliquoted to serum, plasma, red blood cell, and buffy coat fractions. At the next two annual screening visits, serum samples are collected. At the third annual reexamination, cryopreserved whole blood is obtained, in addition to serum, plasma, red blood cell, and buffy coat fractions. At the fourth and fifth years, serum, plasma, and buffy coat are collected. All blood samples are shipped to a central repository for long-term storage at -70 degrees C. Dietary questionnaires and buccal cells for DNA analysis are obtained from nonscreened controls. Cancer cases are identified through annual follow-up questionnaires, and all deaths are identified through vital status tracing mechanisms. Procedures are being developed to obtain archival pathologic material for selected cases of cancer and related diseases. Initial investigations are focusing on the etiology of colorectal cancer and on the operative characteristics of tests for the early detection of colorectal and prostate cancer.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. | 2010 | 20700436 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer. | Meng Y et al. | β | 2025 | β |
| Prediagnostic Serum Concentrations of Per- and Polyfluoroalkyl Substances and Risk of Endometrial Cancer in a US Cohort. | Madrigal JM et al. | β | 2025 | β |
| Serum concentrations of perfluoroalkyl and polyfluoroalkyl substances and risk of ovarian cancer. | Jones RR et al. | β | 2025 | β |
| Altered salivary microbiota associated with high-sugar beverage consumption. | Fan X et al. | β | 2024 | β |
| Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer. | Kwak S et al. | β | 2024 | β |
| Endogenous sex steroid hormones and risk of liver cancer among US men: Results from the Liver Cancer Pooling Project. | Wu Z et al. | β | 2023 | β |
| GWAS Explorer: an open-source tool to explore, visualize, and access GWAS summary statistics in the PLCO Atlas. | Machiela MJ et al. | β | 2023 | β |
| Helicobacter Species and Hepato-Biliary Tract Malignancies: A Systematic Review and Meta-Analysis. | Gros B et al. | β | 2023 | β |
| Elevated dietary carbohydrate and glycemic intake associate with an altered oral microbial ecosystem in two large U.S. cohorts. | Monson KR et al. | β | 2022 | β |
| Cigarette Smoking and Opium Use in Relation to the Oral Microbiota in Iran. | Wu Z et al. | β | 2021 | β |
| Risk of cardiovascular mortality with androgen deprivation therapy in prostate cancer: A secondary analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Controlled Trial. | Butler SS et al. | β | 2021 | β |
| Serum Concentrations of Per- and Polyfluoroalkyl Substances and Risk of Renal Cell Carcinoma. | Shearer JJ et al. | β | 2021 | β |
| A Prospective Study of Circulating Chemokines and Angiogenesis Markers and Risk of Multiple Myeloma and Its Precursor. | Hofmann JN et al. | β | 2020 | β |
| Patients With Reflux Esophagitis Possess a Possible Different Oral Microbiota Compared With Healthy Controls. | Wang B et al. | β | 2020 | β |
| Racial Differences in <i>Helicobacter pylori</i> CagA Sero-prevalence in a Consortium of Adult Cohorts in the United States. | Varga MG et al. | β | 2020 | β |
| A semiparametric efficient estimator in case-control studies for gene-environment independent models. | Liang L et al. | β | 2019 | β |
| Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Esophageal/Gastric Cardia Adenocarcinoma Among Men. | Petrick JL et al. | β | 2019 | β |
| Circulating inflammation markers and colorectal adenoma risk. | Huang WY et al. | β | 2019 | β |
| Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States. | Butt J et al. | β | 2019 | β |
| Antibody Responses to <i>Streptococcus Gallolyticus</i> Subspecies <i>Gallolyticus</i> Proteins in a Large Prospective Colorectal Cancer Cohort Consortium. | Butt J et al. | β | 2018 | β |
| Aspirin Use and Mortality in Two Contemporary US Cohorts. | Huang WY et al. | β | 2018 | β |
| Association between dietary pattern scores and the prevalence of colorectal adenoma considering population subgroups. | Haslam A et al. | β | 2018 | β |
| Association of Coffee and Tea Intake with the Oral Microbiome: Results from a Large Cross-Sectional Study. | Peters BA et al. | β | 2018 | β |
| Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer. | Hayes RB et al. | β | 2018 | β |
| Comparison of the oral microbiome in mouthwash and whole saliva samples. | Fan X et al. | β | 2018 | β |
| Drinking alcohol is associated with variation in the human oral microbiome in a large study of American adults. | Fan X et al. | β | 2018 | β |
| Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. | Fan X et al. | β | 2018 | β |
| Prospective evaluation of serum IL-16 and risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. | Moore A et al. | β | 2018 | β |
| A prospective study of mitochondrial DNA copy number and the risk of prostate cancer. | Moore A et al. | β | 2017 | β |
| Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial. | Liao LM et al. | β | 2017 | β |
| Clinical validation of a blood-based classifier for diagnostic evaluation of asymptomatic individuals with pulmonary nodules. | Birse CE et al. | β | 2017 | β |
| Greater adherence to a Mediterranean diet is associated with lower prevalence of colorectal adenomas in men of all races. | Haslam A et al. | β | 2017 | β |
| Impact of freeze-thaw cycles on circulating inflammation marker measurements. | Huang WY et al. | β | 2017 | β |
| Leukocyte telomere length and renal cell carcinoma survival in two studies. | Callahan CL et al. | β | 2017 | β |
| Oral Microbiome Composition Reflects Prospective Risk for Esophageal Cancers. | Peters BA et al. | β | 2017 | β |
| Semiparametric analysis of complex polygenic gene-environment interactions in case-control studies. | Stalder O et al. | β | 2017 | β |
| The association between Dietary Inflammatory Index scores and the prevalence of colorectal adenoma. | Haslam A et al. | β | 2017 | β |
| The Generalized Higher Criticism for Testing SNP-Set Effects in Genetic Association Studies. | Barnett I et al. | β | 2017 | β |
| The oral fungal mycobiome: characteristics and relation to periodontitis in a pilot study. | Peters BA et al. | β | 2017 | β |
| Cigarette smoking and the oral microbiome in a large study of American adults. | Wu J et al. | β | 2016 | β |
| Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium. | Gaudet MM et al. | β | 2016 | β |
| Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese Individuals. | Hofmann JN et al. | β | 2016 | β |
| A prospective evaluation of C-peptide levels and colorectal adenoma incidence. | Murphy N et al. | β | 2015 | β |
| Association of breast cancer risk loci with breast cancer survival. | Barrdahl M et al. | β | 2015 | β |
| Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions. | Qian DC et al. | β | 2015 | β |
| PLCO: Evolution of an Epidemiologic Resource and Opportunities for Future Studies. | Black A et al. | β | 2015 | β |
| Polybrominated diphenyl ethers and thyroid cancer risk in the Prostate, Colorectal, Lung, and Ovarian Cancer Screening Trial cohort. | Aschebrook-Kilfoy B et al. | β | 2015 | β |
| Risk of follicular lymphoma associated with BCL2 translocations in peripheral blood. | Hirt C et al. | β | 2015 | β |
| Serum biomarkers of habitual coffee consumption may provide insight into the mechanism underlying the association between coffee consumption and colorectal cancer. | Guertin KA et al. | β | 2015 | β |
| The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource. | Carrick DM et al. | β | 2015 | β |
| Thyroid Cancer and Nonsteroidal Anti-Inflammatory Drug Use: A Pooled Analysis of Patients Older Than 40 Years of Age. | Patel D et al. | β | 2015 | β |
| Two susceptibility loci identified for prostate cancer aggressiveness. | Berndt SI et al. | β | 2015 | β |
| Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium. | Joshi AD et al. | β | 2014 | β |
| Analysis of serial ovarian volume measurements and incidence of ovarian cancer: implications for pathogenesis. | Bodelon C et al. | β | 2014 | β |
| A nested case-control study of leukocyte mitochondrial DNA copy number and renal cell carcinoma in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. | Hofmann JN et al. | β | 2014 | β |
| Association between class III obesity (BMI of 40-59 kg/m2) and mortality: a pooled analysis of 20 prospective studies. | Kitahara CM et al. | β | 2014 | β |
| Laboratory detective work identifies a mishandling problem in sample aliquoting. | Zhu C et al. | β | 2014 | β |
| Leveraging family history in population-based case-control association studies. | Ghosh A et al. | β | 2014 | β |
| Microbiome, innate immunity, and esophageal adenocarcinoma. | Baghdadi J et al. | β | 2014 | β |
| Microbiome in reflux disorders and esophageal adenocarcinoma. | Yang L et al. | β | 2014 | β |
| Personal history of diabetes, genetic susceptibility to diabetes, and risk of brain glioma: a pooled analysis of observational studies. | Kitahara CM et al. | β | 2014 | β |
| Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women. | Barrdahl M et al. | β | 2014 | β |
| Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer. | Black A et al. | β | 2014 | β |
| A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma. | Purdue MP et al. | β | 2013 | β |
| A prospective study of leukocyte telomere length and risk of renal cell carcinoma. | Hofmann JN et al. | β | 2013 | β |
| Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association study. | Melin B et al. | β | 2013 | β |
| Metabolomics in epidemiology: sources of variability in metabolite measurements and implications. | Sampson JN et al. | β | 2013 | β |
| Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. | Koutros S et al. | β | 2013 | β |
| A prospective study of circulating adipokine levels and risk of multiple myeloma. | Hofmann JN et al. | β | 2012 | β |
| Association between adult height, genetic susceptibility and risk of glioma. | Kitahara CM et al. | β | 2012 | β |
| Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). | LindstrΓΆm S et al. | β | 2012 | β |
| Pancreatic cancer risk: associations with meat-derived carcinogen intake in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. | Anderson KE et al. | β | 2012 | β |
| Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium. | Birmann BM et al. | β | 2012 | β |
| Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status. | HΓΌsing A et al. | β | 2012 | β |
| Replication of five prostate cancer loci identified in an Asian population--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). | LindstrΓΆm S et al. | β | 2012 | β |
| Serum Ξ±-tocopherol and Ξ³-tocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: a nested case-control study. | Weinstein SJ et al. | β | 2012 | β |
| The association between inflammation-related genes and serum androgen levels in men: the prostate, lung, colorectal, and ovarian study. | Meyer TE et al. | β | 2012 | β |
| A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. | Zhu CS et al. | β | 2011 | β |
| A prospective evaluation of C-reactive protein levels and colorectal adenoma development. | Gunter MJ et al. | β | 2011 | β |
| Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3. | Lindstrom S et al. | β | 2011 | β |
| Diabetes prevalence is associated with serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in US middle-aged Caucasian men and women: a cross-sectional analysis within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. | Brock KE et al. | β | 2011 | β |
| Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. | Campa D et al. | β | 2011 | β |
| Intra-individual variability over time in serum cytokine levels among participants in the prostate, lung, colorectal, and ovarian cancer screening Trial. | Hofmann JN et al. | β | 2011 | β |
| Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis. | Daugherty SE et al. | β | 2011 | β |
| Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. | Cramer DW et al. | β | 2011 | β |
| Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma. | Purdue MP et al. | β | 2011 | β |
| The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: the prostate cancer screening results in context. | Berg CD | β | 2011 | β |
| The use of imputed values in the meta-analysis of genome-wide association studies. | Jiao S et al. | β | 2011 | β |
| A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. | Schumacher FR et al. | β | 2010 | β |
| A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. | LindstrΓΆm S et al. | β | 2010 | β |
| Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin. | Chu LW et al. | β | 2010 | β |
| Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. | Troy JD et al. | β | 2010 | β |
| Body-mass index and mortality among 1.46 million white adults. | Berrington de Gonzalez A et al. | β | 2010 | β |
| Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium. | Canzian F et al. | β | 2010 | β |
| Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer. | Gu F et al. | β | 2010 | β |
| Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and women. | Brock K et al. | β | 2010 | β |
| Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. | Saccone NL et al. | β | 2010 | β |
| Performance of common genetic variants in breast-cancer risk models. | Wacholder S et al. | β | 2010 | β |
| Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma risk. | Wong HL et al. | β | 2010 | β |
| PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3). | Dossus L et al. | β | 2010 | β |
| Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort. | Lacey JV et al. | β | 2009 | β |
| CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium. | Travis RC et al. | β | 2009 | β |
| Mortality results from a randomized prostate-cancer screening trial. | Andriole GL et al. | β | 2009 | β |
| Testing in semiparametric models with interaction, with applications to gene-environment interactions. | Maity A et al. | β | 2009 | β |
| Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer. | Koutros S et al. | β | 2009 | β |
| Genetic variation in sodium-dependent vitamin C transporters SLC23A1 and SLC23A2 and risk of advanced colorectal adenoma. | Erichsen HC et al. | β | 2008 | β |
| IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). | Patel AV et al. | β | 2008 | β |
| Sexually transmissible infections and prostate cancer risk. | Huang WY et al. | β | 2008 | β |
| Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. | Peters U et al. | β | 2008 | β |
| A common 8q24 variant in prostate and breast cancer from a large nested case-control study. | Schumacher FR et al. | β | 2007 | β |
| Adherence to the USDA Food Guide, DASH Eating Plan, and Mediterranean dietary pattern reduces risk of colorectal adenoma. | Dixon LB et al. | β | 2007 | β |
| A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. | Hunter DJ et al. | β | 2007 | β |
| Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer. | Daugherty SE et al. | β | 2007 | β |
| RNASEL Arg462Gln polymorphism and prostate cancer in PLCO. | Daugherty SE et al. | β | 2007 | β |
| Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. | Chen YC et al. | β | 2007 | β |
| Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. | Peters U et al. | β | 2007 | β |
| Bead-based ELISA for validation of ovarian cancer early detection markers. | Scholler N et al. | β | 2006 | β |
| Effect of homeodomain protein NKX3.1 R52C polymorphism on prostate gland size. | Rodriguez Ortner E et al. | β | 2006 | β |
| Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. | Michaud DS et al. | β | 2006 | β |
| High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. | Peters U et al. | β | 2006 | β |
| Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk. | Huang WY et al. | β | 2006 | β |
| Powerful multilocus tests of genetic association in the presence of gene-gene and gene-environment interactions. | Chatterjee N et al. | β | 2006 | β |
| Screening for gynaecological cancers. | Sharma A et al. | β | 2006 | β |
| Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. | Kirsh VA et al. | β | 2006 | β |
| A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. | Hunter DJ et al. | β | 2005 | β |
| CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma. | Hou L et al. | β | 2005 | β |
| Development and application of a simple routine method for the determination of selenium in serum by octopole reaction system ICPMS. | StΓΌrup S et al. | β | 2005 | β |
| Genetic variation in the HSD17B1 gene and risk of prostate cancer. | Kraft P et al. | β | 2005 | β |
| GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma. | Moore LE et al. | β | 2005 | β |
| Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States). | Purdue MP et al. | β | 2005 | β |
| Methods for etiologic and early marker investigations in the PLCO trial. | Hayes RB et al. | β | 2005 | β |
| Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer. | Menon U et al. | β | 2005 | β |
| Association of genetic variants in the calcium-sensing receptor with risk of colorectal adenoma. | Peters U et al. | β | 2004 | β |
| Calcium intake and colorectal adenoma in a US colorectal cancer early detection program. | Peters U et al. | β | 2004 | β |
| Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. | Peters U et al. | β | 2004 | β |
| Prostate-specific antigen and screening for prostate cancer. | Han M et al. | β | 2004 | β |
| Risk behaviours and benign prostatic hyperplasia. | Kang D et al. | β | 2004 | β |
| The economic impact of false-positive cancer screens. | Lafata JE et al. | β | 2004 | β |
| The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise. | Andriole GL et al. | β | 2004 | β |
| Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. | Peters U et al. | β | 2003 | β |
| [Molecular markers for colorectal cancer liver metastases: initial results and perspectives]. | Oudet P et al. | β | 2003 | β |
| Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. | O'Brien B et al. | β | 2000 | β |
| Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. | Hasson MA et al. | β | 2000 | β |
| Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. | Prorok PC et al. | β | 2000 | β |
| The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. | Gohagan JK et al. | β | 2000 | β |